Loading…

JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium

BACKGROUND AND PURPOSE Ca2+ leak from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2s) contributes to cardiomyocyte dysfunction. RyR2 Ca2+ leak has been related to RyR2 phosphorylation. In these conditions, JTV519 (K201), a 1,4‐benzothiazepine derivative and multi‐channel blocker, sta...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2012-10, Vol.167 (3), p.493-504
Main Authors: Sacherer, M, Sedej, S, Wakuła, P, Wallner, M, Vos, MA, Kockskämper, J, Stiegler, P, Sereinigg, M, von Lewinski, D, Antoons, G, Pieske, BM, Heinzel, FR
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 504
container_issue 3
container_start_page 493
container_title British journal of pharmacology
container_volume 167
creator Sacherer, M
Sedej, S
Wakuła, P
Wallner, M
Vos, MA
Kockskämper, J
Stiegler, P
Sereinigg, M
von Lewinski, D
Antoons, G
Pieske, BM
Heinzel, FR
description BACKGROUND AND PURPOSE Ca2+ leak from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2s) contributes to cardiomyocyte dysfunction. RyR2 Ca2+ leak has been related to RyR2 phosphorylation. In these conditions, JTV519 (K201), a 1,4‐benzothiazepine derivative and multi‐channel blocker, stabilizes RyR2s and decrease SR Ca2+ leak. We investigated whether JTV519 stabilizes RyR2s without increasing RyR2 phosphorylation in mice and in non‐failing human myocardium and explored underlying mechanisms. EXPERIMENTAL APPROACH SR Ca2+ leak was induced by ouabain in murine cardiomyocytes. [Ca2+]‐transients, SR Ca2+ load and RyR2‐mediated Ca2+ leak (sparks/waves) were quantified, with or without JTV519 (1 µmol·L−1). Contribution of Ca2+‐/calmodulin‐dependent kinase II (CaMKII) was assessed by KN‐93 and Western blot (RyR2‐Ser2814 phosphorylation). Effects of JTV519 on contractile force were investigated in non‐failing human ventricular trabeculae. KEY RESULTS Ouabain increased systolic and diastolic cytosolic [Ca2+]i, SR [Ca2+], and SR Ca2+ leak (Ca2+ spark (SparkF) and Ca2+ wave frequency), independently of CaMKII and RyR‐Ser2814 phosphorylation. JTV519 decreased SparkF but also SR Ca2+ load. At matched SR [Ca2+], Ca2+ leak was significantly reduced by JTV519, but it had no effect on fractional Ca2+ release or Ca2+ wave propagation velocity. In human muscle, JTV519 was negatively inotropic at baseline but significantly enhanced ouabain‐induced force and reduced its deleterious effects on diastolic function. CONCLUSIONS AND IMPLICATIONS JTV519 was effective in reducing SR Ca2+ leak by specifically regulating RyR2 opening at diastolic [Ca2+]i in the absence of increased RyR2 phosphorylation at Ser2814, extending the potential use of JTV519 to conditions of acute cellular Ca2+ overload.
doi_str_mv 10.1111/j.1476-5381.2012.01995.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3449255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1038228613</sourcerecordid><originalsourceid>FETCH-LOGICAL-j4245-a2d686b3f63146c1dae00f27b41c4960228f59a6d42364c372f97efbf65b98bd3</originalsourceid><addsrcrecordid>eNpdkt1uFCEcxYnR2G31FQyJMakxM_IxMDMXmuhGrdpEL6q3hGGYlpWBFYZt984H8MJn9Elk2nX94IZ_OD9ODuEAADEqcV5PVyWual4w2uCSIExKhNuWlVe3wGIv3AYLhFBdYNw0B-AwxhVCWazZXXBACENt09YL8P3d2WeGW3j8Pvs8hkH3SekIowzKr62Mo1H5cDIq2TTCpSRPoNXyC5Suh2ZcB7_JdG9knLzN6JCcmox30Di4MVPw8zCmYJy-vnKRRumg8-7ntx-DNNa4czhuvZKhN2m8B-4M0kZ9f7cfgU-vX50tT4rTD2_eLl-cFquKVKyQpOcN7-jAKa64wr3UCA2k7iqsqpYjQpqBtZL3FaG8UrQmQ1vroRs469qm6-kReH7ju07dqHul3RSkFetgRhm2wksj_lWcuRDnfiNoVbWEsWxwvDMI_mvScRKjiUpbK532KQqMaJNTcEwz-vA_dOVTcPl5Atecs4ZwSjL14O9E-yi_PyoDj3aAjEraIUinTPzDccoYIjhzz264S2P1dq9jJObiiJWY-yHmfoi5OOK6OOJKvPx4Mk_0FxnIt5E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1766582632</pqid></control><display><type>article</type><title>JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium</title><source>Open Access: PubMed Central</source><source>Wiley</source><creator>Sacherer, M ; Sedej, S ; Wakuła, P ; Wallner, M ; Vos, MA ; Kockskämper, J ; Stiegler, P ; Sereinigg, M ; von Lewinski, D ; Antoons, G ; Pieske, BM ; Heinzel, FR</creator><creatorcontrib>Sacherer, M ; Sedej, S ; Wakuła, P ; Wallner, M ; Vos, MA ; Kockskämper, J ; Stiegler, P ; Sereinigg, M ; von Lewinski, D ; Antoons, G ; Pieske, BM ; Heinzel, FR ; CONTICA investigators</creatorcontrib><description>BACKGROUND AND PURPOSE Ca2+ leak from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2s) contributes to cardiomyocyte dysfunction. RyR2 Ca2+ leak has been related to RyR2 phosphorylation. In these conditions, JTV519 (K201), a 1,4‐benzothiazepine derivative and multi‐channel blocker, stabilizes RyR2s and decrease SR Ca2+ leak. We investigated whether JTV519 stabilizes RyR2s without increasing RyR2 phosphorylation in mice and in non‐failing human myocardium and explored underlying mechanisms. EXPERIMENTAL APPROACH SR Ca2+ leak was induced by ouabain in murine cardiomyocytes. [Ca2+]‐transients, SR Ca2+ load and RyR2‐mediated Ca2+ leak (sparks/waves) were quantified, with or without JTV519 (1 µmol·L−1). Contribution of Ca2+‐/calmodulin‐dependent kinase II (CaMKII) was assessed by KN‐93 and Western blot (RyR2‐Ser2814 phosphorylation). Effects of JTV519 on contractile force were investigated in non‐failing human ventricular trabeculae. KEY RESULTS Ouabain increased systolic and diastolic cytosolic [Ca2+]i, SR [Ca2+], and SR Ca2+ leak (Ca2+ spark (SparkF) and Ca2+ wave frequency), independently of CaMKII and RyR‐Ser2814 phosphorylation. JTV519 decreased SparkF but also SR Ca2+ load. At matched SR [Ca2+], Ca2+ leak was significantly reduced by JTV519, but it had no effect on fractional Ca2+ release or Ca2+ wave propagation velocity. In human muscle, JTV519 was negatively inotropic at baseline but significantly enhanced ouabain‐induced force and reduced its deleterious effects on diastolic function. CONCLUSIONS AND IMPLICATIONS JTV519 was effective in reducing SR Ca2+ leak by specifically regulating RyR2 opening at diastolic [Ca2+]i in the absence of increased RyR2 phosphorylation at Ser2814, extending the potential use of JTV519 to conditions of acute cellular Ca2+ overload.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.2012.01995.x</identifier><identifier>PMID: 22509897</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; arrhythmia ; Biological and medical sciences ; Calcium - metabolism ; calcium leak ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Diastole ; diastolic dysfunction ; Heart ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Humans ; JTV519 ; K201 ; Medical sciences ; Mice ; Myocardium - metabolism ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; non‐failing human myocardium ; Ouabain - pharmacology ; Pharmacology. Drug treatments ; Phosphorylation ; Research Papers ; Ryanodine Receptor Calcium Release Channel - metabolism ; Sarcoplasmic Reticulum - metabolism ; Systole ; Thiazepines - pharmacology</subject><ispartof>British journal of pharmacology, 2012-10, Vol.167 (3), p.493-504</ispartof><rights>2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society</rights><rights>2015 INIST-CNRS</rights><rights>2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.</rights><rights>2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449255/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449255/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26355021$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22509897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sacherer, M</creatorcontrib><creatorcontrib>Sedej, S</creatorcontrib><creatorcontrib>Wakuła, P</creatorcontrib><creatorcontrib>Wallner, M</creatorcontrib><creatorcontrib>Vos, MA</creatorcontrib><creatorcontrib>Kockskämper, J</creatorcontrib><creatorcontrib>Stiegler, P</creatorcontrib><creatorcontrib>Sereinigg, M</creatorcontrib><creatorcontrib>von Lewinski, D</creatorcontrib><creatorcontrib>Antoons, G</creatorcontrib><creatorcontrib>Pieske, BM</creatorcontrib><creatorcontrib>Heinzel, FR</creatorcontrib><creatorcontrib>CONTICA investigators</creatorcontrib><title>JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>BACKGROUND AND PURPOSE Ca2+ leak from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2s) contributes to cardiomyocyte dysfunction. RyR2 Ca2+ leak has been related to RyR2 phosphorylation. In these conditions, JTV519 (K201), a 1,4‐benzothiazepine derivative and multi‐channel blocker, stabilizes RyR2s and decrease SR Ca2+ leak. We investigated whether JTV519 stabilizes RyR2s without increasing RyR2 phosphorylation in mice and in non‐failing human myocardium and explored underlying mechanisms. EXPERIMENTAL APPROACH SR Ca2+ leak was induced by ouabain in murine cardiomyocytes. [Ca2+]‐transients, SR Ca2+ load and RyR2‐mediated Ca2+ leak (sparks/waves) were quantified, with or without JTV519 (1 µmol·L−1). Contribution of Ca2+‐/calmodulin‐dependent kinase II (CaMKII) was assessed by KN‐93 and Western blot (RyR2‐Ser2814 phosphorylation). Effects of JTV519 on contractile force were investigated in non‐failing human ventricular trabeculae. KEY RESULTS Ouabain increased systolic and diastolic cytosolic [Ca2+]i, SR [Ca2+], and SR Ca2+ leak (Ca2+ spark (SparkF) and Ca2+ wave frequency), independently of CaMKII and RyR‐Ser2814 phosphorylation. JTV519 decreased SparkF but also SR Ca2+ load. At matched SR [Ca2+], Ca2+ leak was significantly reduced by JTV519, but it had no effect on fractional Ca2+ release or Ca2+ wave propagation velocity. In human muscle, JTV519 was negatively inotropic at baseline but significantly enhanced ouabain‐induced force and reduced its deleterious effects on diastolic function. CONCLUSIONS AND IMPLICATIONS JTV519 was effective in reducing SR Ca2+ leak by specifically regulating RyR2 opening at diastolic [Ca2+]i in the absence of increased RyR2 phosphorylation at Ser2814, extending the potential use of JTV519 to conditions of acute cellular Ca2+ overload.</description><subject>Animals</subject><subject>arrhythmia</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>calcium leak</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Diastole</subject><subject>diastolic dysfunction</subject><subject>Heart</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Humans</subject><subject>JTV519</subject><subject>K201</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Myocardium - metabolism</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>non‐failing human myocardium</subject><subject>Ouabain - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Research Papers</subject><subject>Ryanodine Receptor Calcium Release Channel - metabolism</subject><subject>Sarcoplasmic Reticulum - metabolism</subject><subject>Systole</subject><subject>Thiazepines - pharmacology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpdkt1uFCEcxYnR2G31FQyJMakxM_IxMDMXmuhGrdpEL6q3hGGYlpWBFYZt984H8MJn9Elk2nX94IZ_OD9ODuEAADEqcV5PVyWual4w2uCSIExKhNuWlVe3wGIv3AYLhFBdYNw0B-AwxhVCWazZXXBACENt09YL8P3d2WeGW3j8Pvs8hkH3SekIowzKr62Mo1H5cDIq2TTCpSRPoNXyC5Suh2ZcB7_JdG9knLzN6JCcmox30Di4MVPw8zCmYJy-vnKRRumg8-7ntx-DNNa4czhuvZKhN2m8B-4M0kZ9f7cfgU-vX50tT4rTD2_eLl-cFquKVKyQpOcN7-jAKa64wr3UCA2k7iqsqpYjQpqBtZL3FaG8UrQmQ1vroRs469qm6-kReH7ju07dqHul3RSkFetgRhm2wksj_lWcuRDnfiNoVbWEsWxwvDMI_mvScRKjiUpbK532KQqMaJNTcEwz-vA_dOVTcPl5Atecs4ZwSjL14O9E-yi_PyoDj3aAjEraIUinTPzDccoYIjhzz264S2P1dq9jJObiiJWY-yHmfoi5OOK6OOJKvPx4Mk_0FxnIt5E</recordid><startdate>201210</startdate><enddate>201210</enddate><creator>Sacherer, M</creator><creator>Sedej, S</creator><creator>Wakuła, P</creator><creator>Wallner, M</creator><creator>Vos, MA</creator><creator>Kockskämper, J</creator><creator>Stiegler, P</creator><creator>Sereinigg, M</creator><creator>von Lewinski, D</creator><creator>Antoons, G</creator><creator>Pieske, BM</creator><creator>Heinzel, FR</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201210</creationdate><title>JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium</title><author>Sacherer, M ; Sedej, S ; Wakuła, P ; Wallner, M ; Vos, MA ; Kockskämper, J ; Stiegler, P ; Sereinigg, M ; von Lewinski, D ; Antoons, G ; Pieske, BM ; Heinzel, FR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j4245-a2d686b3f63146c1dae00f27b41c4960228f59a6d42364c372f97efbf65b98bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>arrhythmia</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>calcium leak</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Diastole</topic><topic>diastolic dysfunction</topic><topic>Heart</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Humans</topic><topic>JTV519</topic><topic>K201</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Myocardium - metabolism</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>non‐failing human myocardium</topic><topic>Ouabain - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Research Papers</topic><topic>Ryanodine Receptor Calcium Release Channel - metabolism</topic><topic>Sarcoplasmic Reticulum - metabolism</topic><topic>Systole</topic><topic>Thiazepines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sacherer, M</creatorcontrib><creatorcontrib>Sedej, S</creatorcontrib><creatorcontrib>Wakuła, P</creatorcontrib><creatorcontrib>Wallner, M</creatorcontrib><creatorcontrib>Vos, MA</creatorcontrib><creatorcontrib>Kockskämper, J</creatorcontrib><creatorcontrib>Stiegler, P</creatorcontrib><creatorcontrib>Sereinigg, M</creatorcontrib><creatorcontrib>von Lewinski, D</creatorcontrib><creatorcontrib>Antoons, G</creatorcontrib><creatorcontrib>Pieske, BM</creatorcontrib><creatorcontrib>Heinzel, FR</creatorcontrib><creatorcontrib>CONTICA investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sacherer, M</au><au>Sedej, S</au><au>Wakuła, P</au><au>Wallner, M</au><au>Vos, MA</au><au>Kockskämper, J</au><au>Stiegler, P</au><au>Sereinigg, M</au><au>von Lewinski, D</au><au>Antoons, G</au><au>Pieske, BM</au><au>Heinzel, FR</au><aucorp>CONTICA investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2012-10</date><risdate>2012</risdate><volume>167</volume><issue>3</issue><spage>493</spage><epage>504</epage><pages>493-504</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>BACKGROUND AND PURPOSE Ca2+ leak from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2s) contributes to cardiomyocyte dysfunction. RyR2 Ca2+ leak has been related to RyR2 phosphorylation. In these conditions, JTV519 (K201), a 1,4‐benzothiazepine derivative and multi‐channel blocker, stabilizes RyR2s and decrease SR Ca2+ leak. We investigated whether JTV519 stabilizes RyR2s without increasing RyR2 phosphorylation in mice and in non‐failing human myocardium and explored underlying mechanisms. EXPERIMENTAL APPROACH SR Ca2+ leak was induced by ouabain in murine cardiomyocytes. [Ca2+]‐transients, SR Ca2+ load and RyR2‐mediated Ca2+ leak (sparks/waves) were quantified, with or without JTV519 (1 µmol·L−1). Contribution of Ca2+‐/calmodulin‐dependent kinase II (CaMKII) was assessed by KN‐93 and Western blot (RyR2‐Ser2814 phosphorylation). Effects of JTV519 on contractile force were investigated in non‐failing human ventricular trabeculae. KEY RESULTS Ouabain increased systolic and diastolic cytosolic [Ca2+]i, SR [Ca2+], and SR Ca2+ leak (Ca2+ spark (SparkF) and Ca2+ wave frequency), independently of CaMKII and RyR‐Ser2814 phosphorylation. JTV519 decreased SparkF but also SR Ca2+ load. At matched SR [Ca2+], Ca2+ leak was significantly reduced by JTV519, but it had no effect on fractional Ca2+ release or Ca2+ wave propagation velocity. In human muscle, JTV519 was negatively inotropic at baseline but significantly enhanced ouabain‐induced force and reduced its deleterious effects on diastolic function. CONCLUSIONS AND IMPLICATIONS JTV519 was effective in reducing SR Ca2+ leak by specifically regulating RyR2 opening at diastolic [Ca2+]i in the absence of increased RyR2 phosphorylation at Ser2814, extending the potential use of JTV519 to conditions of acute cellular Ca2+ overload.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22509897</pmid><doi>10.1111/j.1476-5381.2012.01995.x</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2012-10, Vol.167 (3), p.493-504
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3449255
source Open Access: PubMed Central; Wiley
subjects Animals
arrhythmia
Biological and medical sciences
Calcium - metabolism
calcium leak
Cardiac dysrhythmias
Cardiology. Vascular system
Diastole
diastolic dysfunction
Heart
Heart Ventricles - drug effects
Heart Ventricles - metabolism
Humans
JTV519
K201
Medical sciences
Mice
Myocardium - metabolism
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
non‐failing human myocardium
Ouabain - pharmacology
Pharmacology. Drug treatments
Phosphorylation
Research Papers
Ryanodine Receptor Calcium Release Channel - metabolism
Sarcoplasmic Reticulum - metabolism
Systole
Thiazepines - pharmacology
title JTV519 (K201) reduces sarcoplasmic reticulum Ca2+ leak and improves diastolic function in vitro in murine and human non‐failing myocardium
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A39%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=JTV519%20(K201)%20reduces%20sarcoplasmic%20reticulum%20Ca2+%20leak%20and%20improves%20diastolic%20function%20in%20vitro%20in%20murine%20and%20human%20non%E2%80%90failing%20myocardium&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Sacherer,%20M&rft.aucorp=CONTICA%20investigators&rft.date=2012-10&rft.volume=167&rft.issue=3&rft.spage=493&rft.epage=504&rft.pages=493-504&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.2012.01995.x&rft_dat=%3Cproquest_pubme%3E1038228613%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-j4245-a2d686b3f63146c1dae00f27b41c4960228f59a6d42364c372f97efbf65b98bd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1766582632&rft_id=info:pmid/22509897&rfr_iscdi=true